Approval · Notice of Compliance 25035 · 2021
DRONTAL: Notice of Compliance 25035
Issued January 19, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25035
- Date
- January 19, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRONTAL | 02169495 | Marketed |
Medicinal ingredients
- PRAZIQUANTEL 18.2 MG per TAB
- PYRANTEL PAMOATE 72.6 MG per TAB